HyGene AG
Records under this name other than patents HyGene AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to HyGene AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,972,321 | Monomeric protein of the TGF-β family Term ended Term ended Mar 26, 2021 · From the USPTO record | Term ended | Term ended Mar 26, 2021 | From the USPTO record |
| US 7,569,227 | Monomeric protein of the TGF-β family Term ended Term ended Aug 4, 2020 · From the USPTO record | Term ended | Term ended Aug 4, 2020 | From the USPTO record |
| US 5,686,307 | Serum free medium for use in the formation of a histologically complete living human skin substitute Term ended Term ended no later than Nov 11, 2017 · Low confidence | Term ended | Term ended no later than Nov 11, 2017 | Low confidence |
| US 5,795,781 | Cell competency solution for use in the formation of a histologically-complete, living, human skin substitute Term ended Term ended no later than Aug 18, 2018 · Low confidence | Term ended | Term ended no later than Aug 18, 2018 | Low confidence |
| US 5,834,312 | Process and media for the growth of human epithelia Term ended Term ended no later than Nov 10, 2018 · Low confidence | Term ended | Term ended no later than Nov 10, 2018 | Low confidence |
| US 5,912,175 | Process and media for the growth of human cornea and gingiva Term ended Term ended no later than Jun 15, 2019 · Low confidence | Term ended | Term ended no later than Jun 15, 2019 | Low confidence |